Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults.
about
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsAmantadine and rimantadine for influenza A in children and the elderlyAmantadine and rimantadine for influenza A in children and the elderlyAmantadine and rimantadine for influenza A in children and the elderlyAmantadine and rimantadine for influenza A in adultsAmantadine and rimantadine for preventing and treating influenza A in adultsSusceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug RepositioningOral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adultsMultiple-dose pharmacokinetics of rimantadine in elderly adults.Azapropellanes with anti-influenza a virus activity.Safety and pharmacokinetics of rimantadine small-particle aerosol.In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.Pharmacokinetics of a single dose of rimantadine in young adults and children.1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.Rimantadine: a clinical perspective.A Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic ModelingSimultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application.Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection.Validation of a capillary zone electrophoresis method for determination of rimantadine hydrochloride in Rimantadin100 tablets and the method application to dissolution test monitoring.Pharmacokinetics of amantadine in cats.Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice.Adamantane derivatives: Pharmacological and toxicological properties (review)Anti-influenza therapy: the emerging challenge of resistance
P2860
Q22305941-3AD7F8F4-3E1A-476A-B200-4D2E959B8839Q24187883-278DC4E9-2CA9-4D0D-A10A-F9563D139A5EQ24203853-8847165C-3310-4A06-8D76-BBC7F4C48D17Q24242639-AE1DDFA1-69BB-41DA-A8A3-48EE338D3942Q24246351-60D55758-C358-4E67-BDF5-138409CE6896Q24246830-1E782FA0-AE0D-4137-8758-4010C1037DB6Q28378405-D3456865-C9F0-45F4-9BE7-4CCD0DAFB939Q28547217-4A7DDE4D-E3F7-41F9-A705-33F6841D0036Q30451294-2E40A7CC-B2E7-4E04-94BB-D2073DFFAD36Q30451726-FB53D7A5-34D0-4733-A92D-F3D0978A726EQ33889072-ED18FEEB-BC28-466C-A0CA-373C9CD8B29CQ35282312-0CED199F-3810-4B07-86EA-B8DB2CFB5DB5Q39127478-4A6F0476-F2AB-42EC-89C9-D66F932B816FQ39828452-F9F2B44A-1D7E-4A59-B2DD-BBA122456C3CQ40126502-1A574BCA-B318-473F-895C-66DC16275101Q40441770-64F8A5E9-E9BD-4D31-B26A-694E8A793B56Q41745036-20AF3907-6CEA-4C07-A9D1-96FC075E1B04Q43072391-99D3AD44-06E5-4925-8CBF-C888F1BC4D7AQ43883008-D1A189E0-1013-4C34-B886-4FF6EEF69E61Q44847561-344206DF-23E6-4E76-B60F-8001F53D8087Q46076083-0EF5FF6B-65BD-46D4-9912-3C03E54D8B04Q52012754-2BAC44CC-96BA-465E-BD85-D553464AB7B2Q56675598-B10D9B16-ECFE-4B29-A983-51029E438002Q58066873-D522AC0F-4F64-4D3F-B1CD-25D62E2B1B32
P2860
Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults.
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Comparative single-dose pharma ...... e in young and elderly adults.
@ast
Comparative single-dose pharma ...... e in young and elderly adults.
@en
type
label
Comparative single-dose pharma ...... e in young and elderly adults.
@ast
Comparative single-dose pharma ...... e in young and elderly adults.
@en
prefLabel
Comparative single-dose pharma ...... e in young and elderly adults.
@ast
Comparative single-dose pharma ...... e in young and elderly adults.
@en
P2093
P2860
P356
P1476
Comparative single-dose pharma ...... e in young and elderly adults.
@en
P2093
D A Spyker
F G Hayden
H E Hoffman
P2860
P304
P356
10.1128/AAC.28.2.216
P407
P577
1985-08-01T00:00:00Z